Androgen and prostate cancer: Is the hypothesis dead?

被引:59
作者
Hsing, Ann W. [1 ]
Chu, Lisa W. [1 ,2 ]
Stanczyk, Frank Z. [3 ,4 ]
机构
[1] NCI, NIH, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] NCI, NIH, Off Prevent Oncol, Bethesda, MD 20892 USA
[3] Univ So Calif, Dept Obstet & Gynecol, Keck Sch Med, Los Angeles, CA 90089 USA
[4] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA
关键词
D O I
10.1158/1055-9965.EPI-08-0448
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Data from animal, clinical, and prevention studies support the role of androgen in prostate cancer growth, proliferation, and progression. However, results serum-based epidemiologic studies in humans have been inconclusive. Part of the inconsistency in these findings stems from differences in study population, assay accuracy, intraperson variation, and limited sample size. Recently, data from a large pooled analysis of 18 prospective studies (3,886 cases and 6,438 healthy controls) showed no association between serum androgen and prostate cancer risk. It is not surprising that the pooled analysis did not find a positive link between circulating levels of total testosterone and prostate cancer risk because, individually, few of the 18 studies included in the pooled analysis reported a substantial positive association. The null result, however,, does not pronounce a death sentence for the androgen hypothesis; rather, it underscores the importance of a better understanding of androgen action within the prostate, including the relationship between tissue and serum levels of androgen. In this commentary, we explain why circulating levels of testosterone may not reflect androgen action in the prostate and why tissue levels of androgen, in particular dihydrotestosterone, and the androgen receptor and its coregulators are critical to androgen action in the prostate and should be incorporated in future studies. It is timely to integrate system thinking into our research and use an interdisciplinary approach that involves different disciplines, including epidemiology, endocrinology, pathology, and molecular biology, to help dissect the complex interplay between sex steroids and genetic and lifestyle factors in prostate cancer etiology.
引用
收藏
页码:2525 / 2530
页数:6
相关论文
共 51 条
[1]   Getting over testosterone: Postulating a fresh start for etiologic studies of prostate cancer [J].
Carpenter, William R. ;
Robinson, Whitney R. ;
Godley, Paul A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03) :158-U5
[2]   THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].
CHAMBERLAIN, NL ;
DRIVER, ED ;
MIESFELD, RL .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186
[3]   Molecular epidemiology of prostate cancer: hormone-related genetic loci [J].
Chokkalingam, Anand P. ;
Stanczyk, Frank Z. ;
Reichardt, Juergen K. V. ;
Hsing, Ann W. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :3436-3460
[4]   Androgens and the molecular epidemiology of prostate cancer [J].
Chu, Lisa W. ;
Reichardt, Juergen K. V. ;
Hsing, Ann W. .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2008, 15 (03) :261-270
[5]   The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels [J].
Cote, RJ ;
Skinner, EC ;
Salem, CE ;
Mertes, SJ ;
Stanczyk, FZ ;
Henderson, BE ;
Pike, MC ;
Ross, RK .
BRITISH JOURNAL OF CANCER, 1998, 78 (03) :413-418
[6]   Selective role of an NH2-Terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion-independent prostate cancer cells [J].
Dehm, Scott M. ;
Regan, Kevin M. ;
Schmidt, Lucy J. ;
Tindall, Donald J. .
CANCER RESEARCH, 2007, 67 (20) :10067-10077
[7]   Molecular regulation of androgen action in prostate cancer [J].
Dehm, Scott M. ;
Tindall, Donald J. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) :333-344
[8]   Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells [J].
Dehm, Scott M. ;
Tindall, Donald J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (38) :27882-27893
[9]   Androgen receptor and c-Myc transcription factors as putative partners in the in vivo cross-talk between androgen receptor-mediated and c-Met-mediated signalling pathways [J].
Dudkowska, Magdalena ;
Jaworski, Tomasz ;
Grzelakowska-Sztabert, Barbara ;
Manteuffel-Cymborowska, Malgorzata .
ACTA BIOCHIMICA POLONICA, 2007, 54 (02) :253-259
[10]   The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways [J].
Edwards, J ;
Bartlett, JMS .
BJU INTERNATIONAL, 2005, 95 (09) :1327-1335